SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Shasun gains on reporting Q3 standalone net profit of Rs 104.23 crore

09 Feb 2018 Evaluate

Strides Shasun is currently trading at Rs. 737.25, up by 23.55 points or 3.30% from its previous closing of Rs. 713.70 on the BSE.

The scrip opened at Rs. 695.05 and has touched a high and low of Rs. 739.55 and Rs. 671.55 respectively. So far 71249 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1220.00 on 21-Feb-2017 and a 52 week low of Rs. 640.65 on 06-Feb-2018.

Last one week high and low of the scrip stood at Rs. 739.55 and Rs. 640.65 respectively. The current market cap of the company is Rs. 6519.53 crore.

The promoters holding in the company stood at 31.36%, while Institutions and Non-Institutions held 51.68% and 16.95% respectively.

The company has reported net profit of Rs 104.23 crore for third quarter ended December 31, 2017, as against a net loss of Rs 24.51 crore for the same quarter in the previous year. However, total income of the company decreased by 12.78% to Rs 356.19 crore for Q3FY18 as compared Rs 408.36 crore for the corresponding quarter previous year. 

On consolidate basis, the company has reported 56.56% fall in its net profit at Rs 85.22 crore for the quarter ended December 31, 2017 as compared to Rs 196.17 crore for the corresponding quarter in the FY17. However, total consolidated income of the company increased marginally by 1.70% at Rs 764.71 crore for quarter under review as compared to Rs 751.96 crore for the same quarter ended previous year.

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×